Latest news

EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers
27 Feb 2026

PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases
27 Feb 2026

First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma
26 Feb 2026














